Citation Impact
Citing Papers
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
2006 Standout
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
2011
Adrenalectomy for Familial Pheochromocytoma in the Laparoscopic Era
2002
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Intracerebral haemorrhage
2009 Standout
Cerebral blood flow changes associated with intracerebral hemorrhage
2002
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease
1997
Vascular dementia
2015 Standout
Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?
2009
Intestinal permeability and complications in liver cirrhosis: A prospective cohort study
2012
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability
1995
Adrenal pheochromocytoma remains a frequently overlooked diagnosis
2000
Clinical and molecular aspects of adrenocortical tumourigenesis
2003
AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils
2012
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
The clinical use of structural MRI in Alzheimer disease
2010
Advances in the early detection of Alzheimer's disease
2004
Alzheimer's disease
2011 Standout
PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer
2015
Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis
2009
Cushing's syndrome
2015 Standout
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
2010
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment
1999
Phaeochromocytoma
2005 Standout
Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning
2002
Mild Cognitive Impairment
2011 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
NEUROIMAGING IN DEMENTIA
2000
Medial Temporal Lobe Atrophy and APOE Genotype Do Not Predict Cognitive Improvement upon Treatment with Rivastigmine in Alzheimer’s Disease Patients
2004
Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study
2000
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Colorectal cancer
2013 Standout
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
2010
Primary aldosteronism: renaissance of a syndrome
2007
Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors
2011
Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma
2007
Genetics of human prefrontal function
2003
Central nervous system control of food intake
2000 StandoutNature
Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
2011
Molecular Imaging
2001
Qualitative Estimates of Medial Temporal Atrophy as a Predictor of Progression From Mild Cognitive Impairment to Dementia
2007
Diagnostic Imaging of Colorectal Liver Metastases with CT, MR Imaging, FDG PET, and/or FDG PET/CT: A Meta-Analysis of Prospective Studies Including Patients Who Have Not Previously Undergone Treatment
2010
Systemic amyloidosis
2015 Standout
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
2015
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Intestinal permeability in cirrhotic patients with and without ascites
2005
Laparoscopic Adrenalectomy for Pheochromocytoma
2003
Assessment of Intestinal Permeability and Absorption in Cirrhotic Patients with Ascites Using Combined Sugar Probes
2004
Reversible ischemia around intracerebral hemorrhage: a single-photon emission computerized tomography study
2002
Alzheimer's Disease
2010 Standout
Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors
2001
Whole Brain Segmentation
2002 Standout
High‐dose 131I‐metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma
2003
Blood-Brain Barrier Permeability Correlates with Medial Temporal Lobe Atrophy but Not with Amyloid-β Protein Transport across the Blood-Brain Barrier in Alzheimer’s Disease
2007
Treatment of Elevated Intracranial Pressure in Experimental Intracerebral Hemorrhage: Comparison between Mannitol and Hypertonic Saline
1999
Gastrointestinal dysfunction in liver cirrhosis
2014
Cushing's syndrome
2006 Standout
Review of clinical radioimmunotherapy
2006
Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma
2003
Computationally Designed Bispecific Antibodies using Negative State Repertoires
2016
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
2009
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial
2005 Standout
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
2007
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases
2016
Hippocampal formation glucose metabolism and volume losses in MCI and AD
2001
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
1997
Molecular Mechanisms of Amyloidosis
2003 Standout
Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites
2008
Systemic AA Amyloidosis
2012
Diagnosis and Treatment of Primary Aldosteronism
2011
Spontaneous Intracerebral Hemorrhage
2001 Standout
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion
2002
Outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors
2001
Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI.
1995
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study
2008
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
2011
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
2001
Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia
2010
Long‐term Follow‐up after Adrenalectomy for Primary Aldosteronism
2005
Training labels for hippocampal segmentation based on the EADC‐ADNI harmonized hippocampal protocol
2015
Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
2001
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia
2004
Radial width of the temporal horn: a sensitive measure in Alzheimer disease.
2002
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Measuring the thickness of the human cerebral cortex from magnetic resonance images
2000 Standout
Linear measures of atrophy in mild Alzheimer disease.
1996
Amyloid P component. A critical review
1997
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism
2002
Neuroanatomical Segmentation in MRI: Technological Objectives
1997
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
2004
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High–Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
2012
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
2013
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
2002
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus
2000
Selective Use of Adrenal Venous Sampling in the Lateralization of Aldosterone‐producing Adenomas
2006
Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients
2008
Correspondence of the brain's functional architecture during activation and rest
2009 Standout
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia
2006
Role for IL-4 in macromolecular transport across human intestinal epithelium
1999
LAPAROSCOPIC SURGERY FOR PHEOCHROMOCYTOMA: ADRENALECTOMY, PARTIAL RESECTION, EXCISION OF PARAGANGLIOMAS
1998
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
The organization of the human cerebellum estimated by intrinsic functional connectivity
2011 Standout
Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism
2009
Hippocampal atrophy in Alzheimer disease: Age matters
2006
Reconfigurable asymmetric protein assemblies through implicit negative design
2022 StandoutScienceNobel
Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma
2001
Open Access Series of Imaging Studies (OASIS): Cross-sectional MRI Data in Young, Middle Aged, Nondemented, and Demented Older Adults
2007
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
2004
Primary aldosteronism: diagnostic and treatment strategies
2006
Works of D. Huglo being referenced
Efficacy of iodine-131 6β-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism
1999
Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas
1996
Increased intestinal permeability in bronchial asthma
1996
Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma
2009
Essential hypertension: First reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?
1998
'Localized amyloidosis': 123l-labelled SAP component scintigraphy and labial salivary gland biopsy
1997
Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography
2009
Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis
2001
Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas
1995
FDG–PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study
2010
Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis
1996
Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours
1996
Comparison between Leukoscan® (Sulesomab) and Gallium-67 for the diagnosis of osteomyelitis in the diabetic foot
2005
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation
2007
High Rates of Durable Responses With Anti-CD22 Fractionated Radioimmunotherapy: Results of a Multicenter, Phase I/II Study in Non-Hodgkin's Lymphoma
2010
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
1998
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial.
2004
Perfusion mapping with Tc-HMPAO in cerebral haematomas.
1991
Prospective evaluation of the impact of [18F]fluoro-2-deoxy-d -glucose positron emission tomography of resectable colorectal liver metastases
2005
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
1992
Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
2001
Scintiscans and carcinoid tumors.
1994